Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients
Objective: Fibroblast growth factor 23 (FGF23) has been recognized as an important biomarker of cardiovascular disease and is closely related to inflammation over the past decade. This study aimed to assess the relationship between FGF23 and myocardial injury in patients with sepsis. Methods: We seq...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024039707 |
_version_ | 1797224152572100608 |
---|---|
author | Zheng Yang Jie Wang Jilin Ma Danhong Ren Zhihui Li Kun Fang Zhanli Shi |
author_facet | Zheng Yang Jie Wang Jilin Ma Danhong Ren Zhihui Li Kun Fang Zhanli Shi |
author_sort | Zheng Yang |
collection | DOAJ |
description | Objective: Fibroblast growth factor 23 (FGF23) has been recognized as an important biomarker of cardiovascular disease and is closely related to inflammation over the past decade. This study aimed to assess the relationship between FGF23 and myocardial injury in patients with sepsis. Methods: We sequentially measured serum FGF23, Klotho, biomarkers of inflammation (CRP, IL-6 and WBC), myocardial injury (cTnI and N-terminal B-type natriuretic peptide) and sepsis (procalcitonin) at peak of intercurrent septic shock and after complete resolution or before death in a series of 29 patients with septic shock. 29 healthy adults without infections were used as controls. Results: There was a difference in serum FGF23 level between patients with septic shock and healthy adults (p < 0.0001), and the peak level of FGF23 in septic shock in the survivor group was higher than that after complete remission (p < 0.0001). No statistical difference was found in the level of FGF23 before and after treatment in the death group (p = 0.0947). At the peak of septic shock, FGF23 was significantly correlated with inflammatory markers, CRP (r = 0.8063, p < 0.0001), PCT (r = 0.6091, p = 0.0005) and WBC (r = 0.8312, p < 0.0001), while the correlation with IL-6 was not statistically significant (r = 0.0098, p = 0.9598). At the same time, it was found that FGF23 was significantly correlated with myocardial injury markers, cTNI (r = 0.8475, p < 0.0001) and NTproBNP (r = 0.8505, p < 0.0001). Nevertheless, FGF23 and klotho are not correlated (r = 0.2609, p = 0.1717). Conclusion: In conclusion, in patients with septic shock and myocardial injury, the exacerbation of inflammation in the septic process was accompanied by a abnormal increase of circulating FGF23 level. FGF23 also subsided after the improvement of inflammation, and the opposite was true for patients who did not survive. The up-regulation of FGF23 may be involved in the response of patients to septic shocks, and it is also speculated that FGF23 is involved in the myocardial injury of septic shock. |
first_indexed | 2024-04-24T13:48:35Z |
format | Article |
id | doaj.art-b9f10371c2c94a6e8dbefbbc45fc576f |
institution | Directory Open Access Journal |
issn | 2405-8440 |
language | English |
last_indexed | 2024-04-24T13:48:35Z |
publishDate | 2024-03-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj.art-b9f10371c2c94a6e8dbefbbc45fc576f2024-04-04T05:06:24ZengElsevierHeliyon2405-84402024-03-01106e27939Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patientsZheng Yang0Jie Wang1Jilin Ma2Danhong Ren3Zhihui Li4Kun Fang5Zhanli Shi6Department of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Rheumatology and Immunology, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, ChinaDepartment of Intensive Care Unit, Hangzhou Red Cross Hospital, 208 Huancheng Road East, Hangzhou, 310003, Zhejiang, China; Corresponding author. Department of Intensive Care Unit, Hangzhou Red Cross Hospital, China.Objective: Fibroblast growth factor 23 (FGF23) has been recognized as an important biomarker of cardiovascular disease and is closely related to inflammation over the past decade. This study aimed to assess the relationship between FGF23 and myocardial injury in patients with sepsis. Methods: We sequentially measured serum FGF23, Klotho, biomarkers of inflammation (CRP, IL-6 and WBC), myocardial injury (cTnI and N-terminal B-type natriuretic peptide) and sepsis (procalcitonin) at peak of intercurrent septic shock and after complete resolution or before death in a series of 29 patients with septic shock. 29 healthy adults without infections were used as controls. Results: There was a difference in serum FGF23 level between patients with septic shock and healthy adults (p < 0.0001), and the peak level of FGF23 in septic shock in the survivor group was higher than that after complete remission (p < 0.0001). No statistical difference was found in the level of FGF23 before and after treatment in the death group (p = 0.0947). At the peak of septic shock, FGF23 was significantly correlated with inflammatory markers, CRP (r = 0.8063, p < 0.0001), PCT (r = 0.6091, p = 0.0005) and WBC (r = 0.8312, p < 0.0001), while the correlation with IL-6 was not statistically significant (r = 0.0098, p = 0.9598). At the same time, it was found that FGF23 was significantly correlated with myocardial injury markers, cTNI (r = 0.8475, p < 0.0001) and NTproBNP (r = 0.8505, p < 0.0001). Nevertheless, FGF23 and klotho are not correlated (r = 0.2609, p = 0.1717). Conclusion: In conclusion, in patients with septic shock and myocardial injury, the exacerbation of inflammation in the septic process was accompanied by a abnormal increase of circulating FGF23 level. FGF23 also subsided after the improvement of inflammation, and the opposite was true for patients who did not survive. The up-regulation of FGF23 may be involved in the response of patients to septic shocks, and it is also speculated that FGF23 is involved in the myocardial injury of septic shock.http://www.sciencedirect.com/science/article/pii/S2405844024039707 |
spellingShingle | Zheng Yang Jie Wang Jilin Ma Danhong Ren Zhihui Li Kun Fang Zhanli Shi Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients Heliyon |
title | Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients |
title_full | Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients |
title_fullStr | Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients |
title_full_unstemmed | Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients |
title_short | Fibroblast growth factor 23 during septic shock and myocardial injury in ICU patients |
title_sort | fibroblast growth factor 23 during septic shock and myocardial injury in icu patients |
url | http://www.sciencedirect.com/science/article/pii/S2405844024039707 |
work_keys_str_mv | AT zhengyang fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT jiewang fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT jilinma fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT danhongren fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT zhihuili fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT kunfang fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients AT zhanlishi fibroblastgrowthfactor23duringsepticshockandmyocardialinjuryinicupatients |